Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Milione

Showing results (101-110 of 206) with videos related to

Pageof 21
Sort By:
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Therapeutic Advances in Gastroenterology|August 22, 2020
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidenceSara Pusceddu, Claudio Vernieri, Natalie Prinzi, et al.
Cancers|July 11, 2020
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture AnalysisMassimo Milione, Mattia Boeri, Anna Cantarutti, et al.
Clinical Colorectal Cancer|April 27, 2019
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma PeritoneiAlessandra Raimondi, Salvatore Corallo, Monica Niger, et al.
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Neuroendocrinology|September 27, 2019
Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same CoinAdele Busico, Patrick Maisonneuve, Natalie Prinzi, et al.
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Tumori|October 28, 2024
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjectsOscar Illescas, Antonino Belfiore, Luca Varinelli, et al.
Molecular Oncology|June 9, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingDaniela Di Paolo, Francesca Pontis, Massimo Moro, et al.
Endocrine-Related Cancer|December 3, 2005
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localizationFrancesco Panzuto, Silvia Nasoni, Massimo Falconi, et al.
Pageof 21

Showing results (101-110 of 206) with videos related to

Sort By:
Pageof 21
Oncology|January 19, 2013
Is the standardized uptake value of FDG-PET/CT predictive of pathological complete response in locally advanced rectal cancer treated with capecitabine-based neoadjuvant chemoradiation?Chiara Bampo, Alessandra Alessi, Simona Fantini, et al.
Therapeutic Advances in Gastroenterology|August 22, 2020
The potential role of metformin in the treatment of patients with pancreatic neuroendocrine tumors: a review of preclinical to clinical evidenceSara Pusceddu, Claudio Vernieri, Natalie Prinzi, et al.
Cancers|July 11, 2020
Improved Prognostic Prediction in Never-Smoker Lung Cancer Patients by Integration of a Systemic Inflammation Marker with Tumor Immune Contexture AnalysisMassimo Milione, Mattia Boeri, Anna Cantarutti, et al.
Clinical Colorectal Cancer|April 27, 2019
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma PeritoneiAlessandra Raimondi, Salvatore Corallo, Monica Niger, et al.
Future Oncology (London, England)|August 20, 2019
Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETsNatalie Prinzi, Alessandra Raimondi, Marco Maccauro, et al.
Neuroendocrinology|September 27, 2019
Gastroenteropancreatic High-Grade Neuroendocrine Neoplasms: Histology and Molecular Analysis, Two Sides of the Same CoinAdele Busico, Patrick Maisonneuve, Natalie Prinzi, et al.
Cancers|January 11, 2022
Impact of Diabetes and Metformin Use on Enteropancreatic Neuroendocrine Tumors: Post Hoc Analysis of the CLARINET StudySara Pusceddu, Claudio Vernieri, Massimo Di Maio, et al.
Tumori|October 28, 2024
Effect of anti-inflammatory molecules from food on organoids derived from adenomatous polyps of FAP subjectsOscar Illescas, Antonino Belfiore, Luca Varinelli, et al.
Molecular Oncology|June 9, 2021
Cotargeting of miR-126-3p and miR-221-3p inhibits PIK3R2 and PTEN, reducing lung cancer growth and metastasis by blocking AKT and CXCR4 signallingDaniela Di Paolo, Francesca Pontis, Massimo Moro, et al.
Endocrine-Related Cancer|December 3, 2005
Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localizationFrancesco Panzuto, Silvia Nasoni, Massimo Falconi, et al.
Pageof 21